Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 2/2010

01-02-2010 | Educational Series

Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies

Authors: Gerardo Gutiérrez-Gutiérrez, María Sereno, Ambrosio Miralles, Enrique Casado-Sáenz, Eduardo Gutiérrez-Rivas

Published in: Clinical and Translational Oncology | Issue 2/2010

Login to get access
Metadata
Title
Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies
Authors
Gerardo Gutiérrez-Gutiérrez
María Sereno
Ambrosio Miralles
Enrique Casado-Sáenz
Eduardo Gutiérrez-Rivas
Publication date
01-02-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 2/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/S12094-010-0474-z

Other articles of this Issue 2/2010

Clinical and Translational Oncology 2/2010 Go to the issue

Case Reports

Mixed paratesticular liposarcoma with osteosarcoma elements

Correspondence

Cranial metastases: first sign of colorectal cancer. Is the resection of the primary non-complicated tumour indicated when the metastases have been resected?

Research Articles

Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study

Editorial

The Purple Clinical Series: a useful tool for clinical oncologists to tackle current hot spots in cancer

Educational Series

Biomarkers in bronchopulmonary cancer

Special Article

Breast cancer OncoGuia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits